Akoya Biosciences Inc (AKYA)
3.82
+0.01
(+0.26%)
USD |
NASDAQ |
Apr 25, 16:00
3.93
+0.11
(+2.88%)
Pre-Market: 09:17
Akoya Biosciences Revenue (Quarterly): 26.49M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 26.49M |
| September 30, 2023 | 25.22M |
| June 30, 2023 | 23.52M |
| March 31, 2023 | 21.41M |
| December 31, 2022 | 21.22M |
| September 30, 2022 | 18.85M |
| June 30, 2022 | 17.89M |
| March 31, 2022 | 16.89M |
| Date | Value |
|---|---|
| December 31, 2021 | 16.16M |
| September 30, 2021 | 13.48M |
| June 30, 2021 | 13.07M |
| March 31, 2021 | 12.21M |
| December 31, 2020 | 12.91M |
| September 30, 2020 | 9.954M |
| June 30, 2020 | 8.56M |
| March 31, 2020 | 11.02M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
8.56M
Minimum
Jun 2020
26.49M
Maximum
Dec 2023
16.80M
Average
16.53M
Median
Revenue (Quarterly) Benchmarks
| Bruker Corp | 854.50M |
| Azenta Inc | 154.32M |
| Harvard Bioscience Inc | 28.15M |
| Bionano Genomics Inc | 10.72M |
| Singular Genomics Systems Inc | 1.081M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.80M |
| Total Expenses (Quarterly) | 35.31M |
| EPS Diluted (Quarterly) | -0.20 |
| Enterprise Value | 179.85M |
| Gross Profit Margin (Quarterly) | 62.75% |
| Profit Margin (Quarterly) | -40.78% |
| Earnings Yield | -38.22% |
| Normalized Earnings Yield | -37.39 |